Express Scripts Holding Company (ESRX): M&A News

ESRX – Cigna is nearing deal to acquire Express Scripts in deal that could be announced Thursday – Dow Jones.


Key Facts Surrounding This News Item


  • ESRX had a POWR Rating of B (Buy) coming into today.
  • ESRX was -1.54% below its 10-Day Moving Average coming into today.
  • ESRX was -0.57% below its 20-Day Moving Average coming into today.
  • ESRX was -3.03% below its 50-Day Moving Average coming into today.
  • ESRX was 6.68% above its 100-Day Moving Average coming into today.
  • ESRX was 12.96% above its 200-Day Moving Average coming into today.
  • ESRX had returned -0.08% year-to-date leading up to today’s news, versus a +2.26% return from the benchmark S&P 500 during the same period.

More Info About Express Scripts Holding Company (ESRX)


Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. The company was founded in 1986 and is based in St. Louis, Missouri. View our full ESRX ticker page with ratings, news, and more.

ESRX at a Glance

ESRX Current POWR Rating™
Overall POWR Rating™
ESRX Current Price $98.95 2.08%
More ESRX Ratings, Data, and News

ESRX Price Reaction

The day of this event (Mar. 7, 2018)
ESRX Closing Price$73.42 1.56%
ESRX Volume5,405,600
29.76% from avg
Leading up to this event
ESRX 1-mo return0.49%
After this event
ESRX 1-day return6.45%
ESRX 3-day return4.69%
ESRX 5-day return2.76%

ESRX Price Chart


The Top Stocks For 2019

More Express Scripts Holding Company (ESRX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ESRX News
Page generated in 0.9298 seconds.